Fisetin Modulates Antioxidant Enzymes and Inflammatory Factors to Inhibit Aflatoxin-B1 Induced Hepatocellular Carcinoma in Rats

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Maurya, Brajesh Kumar ^a   Trigun, Surendra Kumar ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXINS; CELL CULTURE; ENZYMES; OXIDATIVE STRESS; RATS;

AFLATOXIN B1 (AFB1); ANTIOXIDANT ENZYME; GLUTATHIONE S-TRANSFERASES; HEPATOCARCINOGENESIS; HEPATOCELLULAR CARCINOMA; NEOPLASTIC LESIONS; PRO-INFLAMMATORY CYTOKINES; REACTIVE OXYGEN SPECIES;

ANTIOXIDANTS;

AFLATOXIN B1; FISETIN; GLUTATHIONE; REACTIVE OXYGEN METABOLITE; ANTIOXIDANT; FLAVONOID; INTERLEUKIN 1ALPHA; OXIDOREDUCTASE; TUMOR NECROSIS FACTOR; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMICAL ANALYSIS; BIOTECHNOLOGY; CONTROLLED STUDY; DNA DAMAGE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MALE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CARCINOMA, HEPATOCELLULAR; CHEMICALLY INDUCED; DRUG EFFECTS; LIVER NEOPLASMS, EXPERIMENTAL; METABOLISM;

AFLATOXIN B1; ANIMALS; ANTIOXIDANTS; CARCINOMA, HEPATOCELLULAR; FLAVONOIDS; INTERLEUKIN-1ALPHA; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NEOPLASM PROTEINS; OXIDATIVE STRESS; OXIDOREDUCTASES; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84949293844     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/1972793     Document Type: Article

References (49)

1. T. B. Kryston, A. B. Georgiev, P. Pissis, and A. G. Georgakilas, "Role of oxidative stress and DNA damage in human carcinogenesis, " Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 711, no. 1-2, pp. 193-201, 2011.
2. M. E. Smela, S. S. Currier, E. A. Bailey, and J. M. Essigmann, "The chemistry and biology of aflatoxin B1: from mutational spectrometry to carcinogenesis, " Carcinogenesis, vol. 22, no. 4, pp. 535-545, 2001.
3. Y. Fujimoto, L. L. Hampton, L.-D. Luo, P. J. Wirth, and S. S. Thorgeirsson, "Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates, " Cancer Research, vol. 52, no. 4, pp. 1044-1046, 1992.
4. G. Landskron, M. De La Fuente, P. Thuwajit, C. Thuwajit, and M. A. Hermoso, "Chronic inflammation and cytokines in the tumor microenvironment, " Journal of Immunology Research, vol. 2014, Article ID149185, 19 pages, 2014.
5. T. Sakurai, G. He, A. Matsuzawa et al., "Hepatocyte necrosis induced by oxidative stress and IL-1 release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis, " Cancer Cell, vol. 14, no. 2, pp. 156-165, 2008.
6. P. Huang, L. Feng, E. A. Oldham, M. J. Keating, andW. Plunkett, "Superoxide dismutase as a target for the selective killing of cancer cells, " Nature, vol. 407, no. 6802, pp. 390-395, 2000.
7. K. A. Conklin, "Cancer chemotherapy and antioxidants, " Journal of Nutrition, vol. 134, pp. 3201S-3204S, 2004.
8. Y. Hasegawa, T. Takano, A. Miyauchi et al., "Decreased expression of glutathione peroxidase mRNA in thyroid anaplastic carcinoma, " Cancer Letters, vol. 182, no. 1, pp. 69-74, 2002.
9. H. Pelicano, D. Carney, and P. Huang, "ROS stress in cancer cells and therapeutic implications, " Drug Resistance Updates, vol. 7, no. 2, pp. 97-110, 2004.
10. K. Aquilano, P. Vigilanza, G. Rotilio, and M. R. Ciriolo, "Mitochondrial damage due to SOD1 deficiency in SH-SY5Y neuroblastoma cells: A rationale for the redundancy of SOD1, " The FASEB Journal, vol. 20, no. 10, pp. 1683-1685, 2006.
11. W.-Q. Ding, J. L. Vaught, H. Yamauchi, and S. E. Lind, "Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: The potential importance of downregulation of superoxide dismutase 1 expression, " Molecular CancerTherapeutics, vol. 3, no. 9, pp. 1109-1117, 2004.
12. H.-L. Ha, H.-J. Shin, M. A. Feitelson, and D.-Y. Yu, "Oxidative stress and antioxidants in hepatic pathogenesis, " World Journal of Gastroenterology, vol. 16, no. 48, pp. 6035-6043, 2010.
13. A. Naiki-Ito, M. Asamoto, N. Hokaiwado et al., "Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens, " Cancer Research, vol. 67, no. 23, pp. 11353-11358, 2007.
14. R. Brigelius-Flohé and A. Kipp, "Glutathione peroxidases in different stages of carcinogenesis, " Biochimica et Biophysica Acta, vol. 1790, no. 11, pp. 1555-1568, 2009.
15. K. B. Singh, B. K. Maurya, and S. K. Trigun, "Activation of oxidative stress and inflammatory factors could account for histopathological progression of aflatoxin-B1 induced hepatocarcinogenesis in rat, "Molecular and Cellular Biochemistry, vol. 401, no. 1-2, pp. 185-196, 2015.
16. A. Bishyee, "The role of inflammation and liver cancer, " Advances in Experimental Medicine and Biology, vol. 816, pp. 401-435, 2014.
17. R. J. Moore, D. M. Owens, G. Stamp et al., "Mice deficient in tumor necrosis factor- are resistant to skin carcinogenesis, " Nature Medicine, vol. 5, no. 7, pp. 828-831, 1999.
18. F. Balkwill, "Tumour necrosis factor and cancer, " Nature Reviews Cancer, vol. 9, no. 5, pp. 361-371, 2009.
19. R. Giavazzi, A. Garofalo, M. R. Bani et al., "Interleukin 1-induced augmentation of experimental metastases from a human melanoma in nude mice, " Cancer Research, vol. 50, no. 15, pp. 4771-4775, 1990.
20. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, "Cancerrelated inflammation, " Nature, vol. 454, no. 7203, pp. 436-444, 2008.
21. V. Afonso, G. Santos, P. Collin et al., "Tumor necrosis factor- down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway, " Free Radical Biology and Medicine, vol. 41, no. 5, pp. 709-721, 2006.
22. Y. Qin, S. Ekmekcioglu, P. Liu et al., "Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma, " Molecular Cancer Research, vol. 9, no. 11, pp. 1537-1550, 2011.
23. K. B. Singh and S. K. Trigun, "Apoptosis of Dalton's lymphoma due to in vivo treatment with emodin is associated with modulations of hydrogen peroxide metabolizing antioxidant enzymes, " Cell Biochemistry and Biophysics, vol. 67, no. 2, pp. 439-449, 2013.
24. M. C. Dias, M. A. M. Rodrigues, M. C. H. Reimberg, and L. F. Barbisan, "Protective effects of Ginkgo biloba against rat liver carcinogenesis, " Chemico-Biological Interactions, vol. 173, no. 1, pp. 32-42, 2008.
25. V. Ravinayagam, R. Jaganathan, S. Panchanadham, and S. Palanivelu, "Potential antioxidant role of tridham in managing oxidative stress against aflatoxin-B1-induced experimental hepatocellular carcinoma, " International Journal of Hepatology, vol. 2012, Article ID 428373, 9 pages, 2012.
26. I. Rahman, S. K. Biswas, and P. A. Kirkham, "Regulation of inflammation and redox signaling by dietary polyphenols, " Biochemical Pharmacology, vol. 72, no. 11, pp. 1439-1452, 2006.
27. K. A. Kang, M. J. Piao, K. C. Kim et al., "Fisetin attenuates hydrogen peroxide-induced cell damage by scavenging reactive oxygen species and activating protective functions of cellular glutathione system, " In Vitro Cellular and Developmental Biology-Animal, vol. 50, no. 1, pp. 66-74, 2014.
28. X. Lu, I. J. Jae, J. C. Han et al., "Fisetin inhibits the activities of cyclin-dependent kinases leading to cell cycle arrest in HT-29 human colon cancer cells, " Journal of Nutrition, vol. 135, no. 12, pp. 2884-2890, 2005.
29. V. M. Adhami, D. N. Syed, N. Khan, andH. Mukhtar, "Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt andmTOR for prostate cancer management, " Biochemical Pharmacology, vol. 84, no. 10, pp. 1277-1281, 2012.
30. T. A. Bhat, D. Nambiar, A. Pal, R. Agarwal, and R. P. Singh, "Fisetin inhibits various attributes of angiogenesis in vitro and in vivo-implications for angioprevention, " Carcinogenesis, vol. 33, no. 2, pp. 385-393, 2011.
31. J. Y. Kim, Y. K. Jeon, W. Jeon, and M. J. Nam, "Fisetin induces apoptosis in Huh-7 cells via downregulation of BIRC8 and Bcl2L2, " Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2259-2264, 2010.
32. N. Ravichandran, G. Suresh, B. Ramesh, and G. Vijaiyan Siva, "Fisetin, a novel flavonol attenuates benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice, " Food and Chemical Toxicology, vol. 49, no. 5, pp. 1141-1147, 2011.
33. A. Mookerjee, J. M. Basu, S. Majumder et al., "A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo, "BMC Cancer, vol. 6, article 267, 2006.
34. O. H. Lowry, N. J. Rosbrough, A. L. Farr, and R. J. Randall, "Protein measurement with the Folin phenol reagent, " The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265-275, 1951.
35. P. T. Schumacker, "Reactive oxygen species in cancer cells: live by the sword, die by the sword, " Cancer Cell, vol. 10, no. 3, pp. 175-176, 2006.
36. G. Liou and P. Storz, "Reactive oxygen species in cancer, " Free Radical Research, vol. 44, no. 5, pp. 479-496, 2010.
37. R. K. Koiri, S. K. Trigun, and L. Mishra, "Activation of p53 mediated glycolytic inhibition-oxidative stress-apoptosis pathway in Dalton's lymphoma by a ruthenium (II)-complex containing 4-carboxyN-ethylbenzamide, " Biochimie, vol. 110, pp. 52-61, 2015.
38. G. Ramakrishnan, H. R. B. Raghavendran, R. Vinodhkumar, and T. Devaki, "Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats, " Chemico-Biological Interactions, vol. 161, no. 2, pp. 104-114, 2006.
39. S. Higa, T. Hirano, M. Kotani et al., "Fisetin a flavonol, inhibits TH2-type cytokine production by activated human basophils, " Journal of Allergy and Clinical Immunology, vol. 111, pp. 1299-1306, 2003.
40. N. Li, T. D. Oberley, L. W. Oberley, and W. Zhong, "Overexpression of manganese superoxide dismutase in DU145 human prostate carcinoma cells hasmultiple effects on cell phenotype, " Prostate, vol. 35, no. 3, pp. 221-233, 1998.
41. Y. Zhang, W. Zhao, H. J. Zhang, F. E. Domann, and L. W. Oberley, "Overexpression of copper zinc superoxide dismutase suppresses human glioma cell growth, " Cancer Research, vol. 62, no. 4, pp. 1205-1212, 2002.
42. T. P. Szatrowski and C. F. Nathan, Production of large amounts of hydrogen peroxide by human tumor cells, Cancer Research,vol. 51, no. 3, pp. 794-798, 1991.
43. P. Amstad, A. Peskin, G. Shah et al., "The balance between Cu, Zn-superoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress, " Biochemistry, vol. 30, no. 38, pp. 9305-9313, 1991.
44. P. Amstad, R. Moret, and P. Cerutti, "Glutathione peroxidase compensates for the hypersensitivity of Cu-Zn-superoxide dismutase overproducers to oxidant stress, " The Journal of Biological Chemistry, vol. 269, no. 3, pp. 1606-1609, 1994.
45. E. O. Farombi, B. I. Olowu, and G. O. Emerole, "Effect of three structurally related antimalarial drugs on liver microsomal components and lipid peroxidation in rats, " Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, vol. 126, no. 3, pp. 217-224, 2000.
46. H. U. Nwanjo and G. O. Oze, "Oxidative imbalance and nonenzymic antioxidant status in pulmonary tuberculosis infected subjects: carcinogenic potential, " Pakistan Journal of Nutrition, vol. 6, no. 6, pp. 590-592, 2007.
47. X. G. Lei, "In vivo antioxidant role of glutathione peroxidase: evidence from knockout mice, " Methods in Enzymology, vol. 347, pp. 213-225, 2002.
48. J. L. Schwartz and G. Shklar, "Glutathione inhibits experimental oral carcinogenesis, p53 expression, and angiogenesis, " Nutrition and Cancer, vol. 26, no. 2, pp. 229-236, 1996.
49. S. Nowsheen, K. Aziz, T. B. Kryston, N. F. Ferguson, and A. Georgakilas, "The interplay between inflammation and oxidative stress in carcinogenesis, " CurrentMolecularMedicine, vol. 12, no. 6, pp. 672-680, 2012.